TMS for Exposure Therapy Resistant OCD
RecruitingNCT05331937Phase: PHASE3Started 2022-05-16
Summary
TETRO is a multi-center placebo-controlled double-blind randomized controlled trial with an intervention phase of 5-7 weeks and a follow-up phase of 12 months in 250 adult (18 years and older) OCD pat
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
None
Locations
Amsterdam UMC, location VU Medical CenterAmsterdam, North Holland, Netherlands
GGZ inGeestAmsterdam, Netherlands
NeurocareEindhoven, Netherlands
NeurocareGroningen, Netherlands
Maastricht UMC+Maastricht, Netherlands
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05331937